LONG-TERM CARDIOVASCULAR COMPLICATIONS IN ONCOLOGIC PATIENTS AFTER ANTITUMOR THERAPY (>1 YEAR)
Oncological and cardiovascular diseases (CVD) hold a leading position among the causes of mortality in many countries of the world, including the Russian Federation [1]. In recent years, a decrease in mortality due to oncologic diseases (OD) is noted around the world thanks to early diagnostics, as...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
InterMedservice
2019-09-01
|
| Series: | Евразийский Кардиологический Журнал |
| Subjects: | |
| Online Access: | https://www.heartj.asia/jour/article/view/337 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849245056434700288 |
|---|---|
| author | M. L. Kazantseva E. V. Oshchepkova M. A. Saidova A. A. Avalyan I. F. Chazova |
| author_facet | M. L. Kazantseva E. V. Oshchepkova M. A. Saidova A. A. Avalyan I. F. Chazova |
| author_sort | M. L. Kazantseva |
| collection | DOAJ |
| description | Oncological and cardiovascular diseases (CVD) hold a leading position among the causes of mortality in many countries of the world, including the Russian Federation [1]. In recent years, a decrease in mortality due to oncologic diseases (OD) is noted around the world thanks to early diagnostics, as well as to the development and implementation of new technologies and therapeutic treatment strategies (chemotherapy, targeted and radiation therapy). Among patients with OD who received chemotherapy and radiation therapy, CVD is one of the leading causes of poor prognosis, including lethal outcomes [2-5]. The long-term cardiotoxic effects of antitumor therapy (chemotherapy, radiation therapy) reduce the survival rate and quality of life of patients who suffer from cancer. Thus, early diagnostics and timely detection of the cardiotoxic effects that follow antitumor treatment is one of the main tasks of cardio-oncology. |
| format | Article |
| id | doaj-art-488693a33f5848b08fd9182f34f2e866 |
| institution | Kabale University |
| issn | 2225-1685 2305-0748 |
| language | Russian |
| publishDate | 2019-09-01 |
| publisher | InterMedservice |
| record_format | Article |
| series | Евразийский Кардиологический Журнал |
| spelling | doaj-art-488693a33f5848b08fd9182f34f2e8662025-08-20T03:58:56ZrusInterMedserviceЕвразийский Кардиологический Журнал2225-16852305-07482019-09-0103506410.38109/2225-1685-2019-3-50-64336LONG-TERM CARDIOVASCULAR COMPLICATIONS IN ONCOLOGIC PATIENTS AFTER ANTITUMOR THERAPY (>1 YEAR)M. L. Kazantseva0E. V. Oshchepkova1M. A. Saidova2A. A. Avalyan3I. F. Chazova4A.L. Myasnikov Clinical Cardiology Institute Federal State Budgetary Institution «National Medical Research Center of Cardiology,» Russian Ministry of HealthcareA.L. Myasnikov Clinical Cardiology Institute Federal State Budgetary Institution «National Medical Research Center of Cardiology,» Russian Ministry of HealthcareA.L. Myasnikov Clinical Cardiology Institute Federal State Budgetary Institution «National Medical Research Center of Cardiology,» Russian Ministry of HealthcareA.L. Myasnikov Clinical Cardiology Institute Federal State Budgetary Institution «National Medical Research Center of Cardiology,» Russian Ministry of HealthcareA.L. Myasnikov Clinical Cardiology Institute Federal State Budgetary Institution «National Medical Research Center of Cardiology,» Russian Ministry of HealthcareOncological and cardiovascular diseases (CVD) hold a leading position among the causes of mortality in many countries of the world, including the Russian Federation [1]. In recent years, a decrease in mortality due to oncologic diseases (OD) is noted around the world thanks to early diagnostics, as well as to the development and implementation of new technologies and therapeutic treatment strategies (chemotherapy, targeted and radiation therapy). Among patients with OD who received chemotherapy and radiation therapy, CVD is one of the leading causes of poor prognosis, including lethal outcomes [2-5]. The long-term cardiotoxic effects of antitumor therapy (chemotherapy, radiation therapy) reduce the survival rate and quality of life of patients who suffer from cancer. Thus, early diagnostics and timely detection of the cardiotoxic effects that follow antitumor treatment is one of the main tasks of cardio-oncology.https://www.heartj.asia/jour/article/view/337cardio-oncologycardiotoxicityarterial hypertensionheart failureoncologyspeckle tracking technologyradiation therapychemotherapy |
| spellingShingle | M. L. Kazantseva E. V. Oshchepkova M. A. Saidova A. A. Avalyan I. F. Chazova LONG-TERM CARDIOVASCULAR COMPLICATIONS IN ONCOLOGIC PATIENTS AFTER ANTITUMOR THERAPY (>1 YEAR) Евразийский Кардиологический Журнал cardio-oncology cardiotoxicity arterial hypertension heart failure oncology speckle tracking technology radiation therapy chemotherapy |
| title | LONG-TERM CARDIOVASCULAR COMPLICATIONS IN ONCOLOGIC PATIENTS AFTER ANTITUMOR THERAPY (>1 YEAR) |
| title_full | LONG-TERM CARDIOVASCULAR COMPLICATIONS IN ONCOLOGIC PATIENTS AFTER ANTITUMOR THERAPY (>1 YEAR) |
| title_fullStr | LONG-TERM CARDIOVASCULAR COMPLICATIONS IN ONCOLOGIC PATIENTS AFTER ANTITUMOR THERAPY (>1 YEAR) |
| title_full_unstemmed | LONG-TERM CARDIOVASCULAR COMPLICATIONS IN ONCOLOGIC PATIENTS AFTER ANTITUMOR THERAPY (>1 YEAR) |
| title_short | LONG-TERM CARDIOVASCULAR COMPLICATIONS IN ONCOLOGIC PATIENTS AFTER ANTITUMOR THERAPY (>1 YEAR) |
| title_sort | long term cardiovascular complications in oncologic patients after antitumor therapy 1 year |
| topic | cardio-oncology cardiotoxicity arterial hypertension heart failure oncology speckle tracking technology radiation therapy chemotherapy |
| url | https://www.heartj.asia/jour/article/view/337 |
| work_keys_str_mv | AT mlkazantseva longtermcardiovascularcomplicationsinoncologicpatientsafterantitumortherapy1year AT evoshchepkova longtermcardiovascularcomplicationsinoncologicpatientsafterantitumortherapy1year AT masaidova longtermcardiovascularcomplicationsinoncologicpatientsafterantitumortherapy1year AT aaavalyan longtermcardiovascularcomplicationsinoncologicpatientsafterantitumortherapy1year AT ifchazova longtermcardiovascularcomplicationsinoncologicpatientsafterantitumortherapy1year |